Excitement in the β-lactamase arena

Journal of Antimicrobial Chemotherapy

Volumn 24, Issue 6, 1989, Pages 831-836

  Bush, Karen ^a  

^a Squibb Inst for Medical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFALORIDINE; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; QUINOLONE DERIVATIVE; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; GRAM NEGATIVE BACTERIUM; NONHUMAN; PRIORITY JOURNAL; REVIEW;

BACTERIAL INFECTIONS; BETA-LACTAMASES; DRUG RESISTANCE, MICROBIAL; HUMAN;

EID: 0024816771     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/24.6.831     Document Type: Article

References (43)

1. Ambler, R. P. & Scott, G. K. (1978). Partial amino acid tequence of penicillinase coded by Escherichia coli plasmid R6K. Proceedings of the National Academy of Sciences of the United States of America 75, 3732-6
2. Barthillmy, M., Piduzzi, J., Ben Yaghlane, H. & Labia, R. (1988a). Single amino acid substitution between SHV-1 /Mactamase and cefotaxime- hydrolyzing SHV-2 enzyme. FEBS Letters 231, 217-20
3. Barthfcteny, M., Peduzzi, J. & Labia, R. (1988b). Complete amino add sequence of p453-plasmid- mediated PIT-2 /Mactamase (SHV-1). Biochemical Journal 251, 73-9
4. Bauemfeind, A. & Hbrl, G. (1987). Novel R-factor borne-lactamase of Escherichia coli conferring resistance to cephalosporins. Infection 15, 257-9
5. Ben Redjeb, S., Ben Yaghlane, H., Boujnah, A., Philippon, A. & Labia, IL (1988). Synergy between clavulanic add and newer /J-lactams on nine clinical isolates of Klebsiella pneumoniae, Escherichia coli and Salmonella typhimurium resistant to third-generation cephalosporins. Journal of Antimicrobial Chemotherapy 21, 263-6
6. Bush, K. (1989). Classification of -lactamases: groups I, 2a, 2b, and 2b. Antimicrobial Agents and Chemotherapy 33, 264-70
7. Bush, K. & Singer, S. B. (1989). Biochemical characteristics of extended broad spectrum /J- lactamases. Infection, in press
8. Bush, K., Tanaka, S. K., Bonner, D. P. & Sykes, R. B. (1985). Resistance caused by decreased penetration of /1-lactam antibiotics into Enterobacter cloacae. Antimicrobial Agents and Chemotherapy 27, 555-60
9. Chanal, C. M., Sirot, D. L., Labia, R., Petit, A., Morand, A., Sirot, J. L. el al. (1988). Comparative study of a novel plasmid-mediated /Mactamase. CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy 32, 1660-5
10. Collatz, E., Tran Van Nhieu, G., Billot-KJein, D., Williamson, R. & Gutmann, L. (1989). Substitution of serine for arginine in position 162 of TEM-type)-lactamases extends the substrate profile of mutant enzymes, TEM-7 and TEM-101, to ceftazidime and aztreonam. Gene 78, 349-54
11. Curtis, N. A. C., Eisenstadt, R. L., Rudd, C. & White, A J. (1986). Inducible Type I /I-lactamasesof Gram-negative bacteria and resistance to fi- lactam antibiotics. Journal of Antimicrobial Chemotherapy 17, 51-61
12. Deschaseaux, M. L., Jouvenot, M., Adessi, G. L. & Michel-Briand, Y. (1988). Two presumed novel /f- lactamases in members of the family Enterobacteriaceae. Journal of Antimicrobial Chemotherapy 21, 133-5
13. Drabu, Y. J., Blakemore, P. H., Cox, D. M. & McLaren, A. (1989). Plasmid-mediated ceftazidime resistance. Journal of Antimicrobial Chemotherapy 23, 287-90
14. Gutmann, L., Ferri, B., Goldstein, F. W., Rizk, N., Pinto-Sdiuster, E., Acar, J. F. et al. (1989). SHV- 5, a novel SHV-type /Mactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrobial Agents and Chemotherapy 33, 951-6
15. Gutmann, L., Kitzis, M. D., Billot-Klein, D., Goldstein, F., Tran Van Nhieu, G., Lu, T. et al. Plasmid-mediated ?-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam. Reviews of Infectious Diseases 10, 860-6
16. Hancock, R. E. W. & Woodruff, W. A. (1988). Roles of porin and /I-lactamase in /L lactam resistance to Pseudomonas aeruginosa. Reviews of Infectious Diseases 10, 770-5
17. Jacoby, G. A., Medeiros, A. A., O’Brien, T. F., Pinto, M. E. & Jiang, H. (1988). Broad-spectrum, transmissible /Manamases. New England Journal of Medicine 319, 723-4
18. Jarlier, V., Nicolas, M.-H., Fournier, G. & Philippon, A. (1988). Extended broad-spectrum 0- lartatnases conferring transferable resistance to newer /I-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Reviews of Infectious Diseases 10, 867-78
19. Kitzis, M. D., Billot-Klein, D., Goldstein, F. W., Williamson, R., Tran Van Nhieu, G., Cartet, J. et al. (1988). Dissemination of the novel plasmid- mediated /Mactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by /Mactamase inhibitors. Antimicrobial Agents and Chemotherapy 32, 9-14
20. Kliebe, C., Nies, B. A., Meyer, J. F., Tolxdorff- Neutzling, R. M. & Wiedemann, B. (1985). Evolution of plasmid-coded resistance to broad- spectrum cephalosporins. Antimicrobial Agents and Chemotherapy 28, 302-7
21. Knothe, H., Shah, P., Krcmery, V., Antal, M. & Mitsuhashi, S. (1983). Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11, 315-7
22. Labia, R., Morand, A., Tiwari, K., Sirot, J., Sirot, D. & Petit, A. (1988). Interactions of new plasmid- mediated -lactamases with third-generation cephalosporins. Reviews of Infectious Diseases 10, 885-91
23. Matthew, M. (1979). Plasmid-mediated /Mactamascs of Gram-negative bacteria: properties and distribution. Journal of Antimicrobial Chemotherapy 5, 349-58
24. Matthew, M., Hedges, R. W. & Smith, J. T. (1979). Types of /Mactamase determined by plasmids in Gram-negative bacteria. Journal of Bacteriology 138, 657-62
25. Medeiros, A. A. (1984). J-Lactamases. British Medical Bulletin 40, 18-27
26. Moore, W. J. (1962). Physical Chemistry. 3rd edn, p. 209. Prentice-Hafl, Englewood Cliffs, NJ
27. Pan go n, B., Bizet, C., Burfc, A., Pichon, F., Philippon, A., Regnier, B. et al. (1989). In vivo selection of a cephamycin-resistant porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 /Mactamase. Journal of Infectious Diseases 159, 1005-6
28. Payne, D. J., Marriott, M. S. & Amyes, S. G. B. TEM-E1: a novel /Mactamase conferring resistance to ceftazidime. FEMS Microbiology Letters 59, 97-100
29. Petit, A., Sirot, D. L., Chanal, C. M., Sirot, J. L., Labia, R., Gerbaud, G. et al. (1988). Novel plasmid-mediated /Mactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy 32, 626-30
30. Quinn, J. P., Miyashiro, D., Sahm, D., Flamm, R. & Bush, K. (1989). Novel plasmid-mediated fi- lactamasc (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 33, 1451-6
31. Roy, C., Segura, C., Tirado, M., Reig, R., Hermida, M., Teruel, D. et al. (1985). Frequency of plasmid- determined beta-lactamases in 680 consecutively isolated strains of Enterobacteriaceae. European Journal of Clinical Microbiology 4, 146-7
32. Schultz, S. C. & Richards, J. H. (1986). Site- saturation studies of /L lactamase: production and characterization of mutant /Mactamascs with all possible amino add substitutions at residue 71. Proceedings of the National Academy of Sciences of the United Stales of America 83, 1588-92
33. Simpson, I. N., Harper, P. B. & O’Callaghan, C. H. (1980). Prindpal /Mactamascs responsible for resistance to /Llactam antibiotics in urinary tract infections. Antimicrobial Agents and Chemotherapy 17, 929-36
34. Sirot, D., Sirot, J., Labia, R., Morand, A., Courvalin, P., DarfeuiUe-Michaud, A. et al. (1987a). Transferable resistance to third- generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel /Mactamase. Journal of Antimicrobial Chemotherapy 20, 323-34
35. Sirot, J., Chanal, C., Petit, A., Sirot, D., Labia, R. & Gerbaud, G. (1988). Klebsiella pneumoniae and other Enterobacteriaceae producing novel plasmid-mediated ^-lactamases markedly active against third-generation cephalosporins: epidemiologic studies. Reviews of Infectious Diseases 10, 850-9
36. Sirot, J., Labia, R. & Thabaut, A. (19876). Klebsiellapneumoniae strains more resistant to ceftazidime than to other third-generation cephalosporins. Journal of Antimicrobial Chemotherapy 20, 611-2
37. Sougakoff, W., Goussard, S., Gerbaud, G. & Courvalin, P. (1988). Plasmid-mediated resistance to third-generation cephalosporins caused by point mutations in TEM-type penicillinase genes. Reviews of Infectious Diseases 10, 879-84
38. Sougakoff, W., Petit, A., Goussard, S., Sirot, D., Bure, A. & Courvalin, P. (1989). Characterization of the plasmid genes bldT-A and' bioT-S which encode the broad-spectrum ^-lactamases TEM-4 and TEM-S in Enterobacteriaceae. Gene 78, 339-48
39. Spencer, R. C., Wheat, P. F., Winstanley, T. G., Cox, D. M., & Plested, S. J. (1987). Novel 0- lactamase in a clinical isolate of Klebsiella pneumoniae conferring unusual resistance to fi- lactam antibiotics. Journal of Antimicrobial Chemotherapy 20, 919-21
40. Sutcliffe, J. G. (1978). Nucleotide sequence of the ampidllin resistance gene of Escherichia coli plasmid pBR322. Proceedings of the National Academy of Sciences of the United States of America ns, 3737-41
41. Thatcher, D. R, (1975). Progress on penicillinase. Nature 255, 526.Vu, H. Sc
42. Nikaido, H. (1985). Role of /Madam hydrolysis in the mechanism of resistance of a fi- lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum /Madams. Antimicrobial Agents and Chemotherapy 27, 393-8
43. Vuye, A., Verschraegen, G. & Claeys, G. (1989). Plasmid-mediated /!-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime. Antimicrobial Agents and Chemotherapy 33, 757-61